Skip to content
sellWeak10b5-1 plan

Peter Virsik sold $4,164 of EPIX

Chief Operating Officer at ESSA Pharma Inc.. 694 shares at an average of $6.00, traded Sep 9, 2024, filed Sep 9, 2024.

Warning score
0
Value
$4,164
694 shares
Holdings after
8,470
-8% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    COO
    +20
  • Trade size
    $4k at market
    0
  • Share of holdings sold
    Sold 7.6% of holdings
    0
  • Cluster
    No other insider selling within 14 days
    0
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0000950170-24-104661, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Sep 9, 2024SOpen-market sale
Common Shares10b5-1
-694$6.00$4,1648,470Sep 9, 2024

Related signals

Other insiders at ESSA Pharma Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
12Weak
EPIXsell
ESSA Pharma Inc.
Bvf Partners L P/il
owner
$293
156 shares
-0%
57Moderate
EPIXsell
ESSA Pharma Inc.
Biotech Growth N V
owner
$12M
7,879,583 shares
-100%
0Weak
EPIXsell10b5-1
ESSA Pharma Inc.
Peter Virsik
Chief Operating Officer
$4,185
694 shares
-8%
5Weak
EPIXsell10b5-1
ESSA Pharma Inc.
Peter Virsik
Chief Operating Officer
$13k
2,082 shares
-19%
0Weak
EPIXsell10b5-1
ESSA Pharma Inc.
Peter Virsik
Chief Operating Officer
$4,823
694 shares
-6%
0Weak
EPIXsell10b5-1
ESSA Pharma Inc.
Peter Virsik
Chief Operating Officer
$5,510
694 shares
-5%
0Weak
EPIXsell10b5-1
ESSA Pharma Inc.
Peter Virsik
Chief Operating Officer
$6,232
694 shares
-5%
26Weak
EPIXsell10b5-1
ESSA Pharma Inc.
Peter Virsik
Chief Operating Officer
$749k
72,782 shares
-85%
0Weak
EPIXsell10b5-1
ESSA Pharma Inc.
Peter Virsik
Chief Operating Officer
$11k
1,194 shares
-9%
0Weak
EPIXsell10b5-1
ESSA Pharma Inc.
Peter Virsik
Chief Operating Officer
$17k
1,718 shares
-11%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Peter Virsik sold $4,164 of EPIX | InsiderTell